New hope for hard-to-treat colorectal cancer? early trial launches
NCT ID NCT07363408
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests two immunotherapy drugs (ivonescimab and ADG126) alone or with chemotherapy in 30 adults with advanced or metastatic MSS colorectal cancer, a type that doesn't respond well to standard immunotherapy. The main goal is to find safe doses and check for side effects. The study is not yet recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MICROSATELLITE STABLE COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new blood test spot colorectal cancer return earlier?
- Experimental drug combo targets Hard-to-Treat GI cancers
- Wheat germ supplement studied for immune boost in advanced cancer
- Could a pill help the liver regrow and make more cancer surgeries possible?
- Can a smaller dose of this cancer drug still work? new trial aims to find out
- New immunotherapy combo aims to wipe out hidden colorectal cancer cells